Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
sevoflurane, Quantity: 250 mL
Baxter Healthcare Pty Ltd
Sevoflurane
Inhalation
Excipient Ingredients:
Inhalation
1 x 250mL
(S4) Prescription Only Medicine
For induction and maintenance of general anaesthesia in adults and paediatric patients undergoing surgery.
Visual Identification: Clear colourless liquid.; Container Type: Bottle; Container Material: Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2004-08-03
SEVOFLURANE BAXTER (sevoflurane) Consumer Medicine Information SEVOFLURANE BAXTER CMI 060501 Page 1 of 4 Baxter SEVOFLURANE BAXTER WHAT IS IN THIS LEAFLET? This leaflet answers some common questions about sevoflurane. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking sevoflurane against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. WHAT SEVOFLURANE IS USED FOR. Sevoflurane belongs to a group of medicines called halogenated anaesthetic agents, which are breathed in to induce (commence) and/or maintain anaesthesia. This medicine is added by an anaesthetist to the air you breathe when you go for surgery. It is a colourless liquid supplied in a bottle. It is given by your anaesthetist using a vaporiser, which turns the liquid into a gas so that you can breathe it in. Sevoflurane is used for inducing and maintaining heavy sleep needed during surgery. The drug produces loss of consciousness and loss of pain sensations during surgery. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. BEFORE YOU RECEIVE SEVOFLURANE. _ _ _Before you are due to receive sevoflurane. _ You must tell your doctor if: 1. You have previously had any problems with a general anaesthetic. 2. You, or anyone in your family has malignant hyperthermia (a rare type of severe fever). 3. You have recently had any other general anaesthetic, or had more than one general anaesthetic over a short period of time. 4. You have had sevoflurane before and experienced an allergic reaction. SEVOFLURANE BAXTER (sevoflurane) Consumer Medicine Information SEVOFLURANE BAXTER CMI 060501 Page 2 of 4 Baxter 5. You have or have had any of the following medical conditions: Any problems with your liver including hepatitis. Brain disorders Read the complete document
Sevoflurane Version 2.0 1 of 23 AUSTRALIAN PRODUCT INFORMATION BAXTER SEVOFLURANE 1 NAME OF THE MEDICINE Sevoflurane 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sevoflurane 100% w/v. _List of excipients:_ None 3 PHARMACEUTICAL FORM Sevoflurane volatile liquid for inhalation, a non-flammable and nonexplosive liquid administered by vaporization, is a halogenated general inhalation anaesthetic drug. Sevoflurane is a clear, colourless, stable liquid containing no additives or chemical stabilizers. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sevoflurane is indicated for induction and maintenance of general anesthesia in adult and paediatric patients undergoing surgery. 4.2 DOSE AND METHOD OF ADMINISTRATION Sevoflurane should be administered only by persons trained in the administration of general anaesthesia. Facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment and circulatory resuscitation must be immediately available. Sevoflurane is administered by inhalation. The concentration of Sevoflurane being delivered from a vaporizer during anesthesia should be known. This may be accomplished by using a vaporizer calibrated specifically for sevoflurane. Filling occurs directly from the bottle via an integrated valve or in case of a bottle without integrated valve, with the use of an appropriate adaptor designed specifically to fit the sevoflurane vaporiser. _REPLACEMENT OF DESICCATED CO_ _2_ _ ABSORBENTS: _ CO 2 ABSORBENTS SHOULD NOT BE ALLOWED TO DRY OUT WHEN INHALATIONAL ANAESTHETICS ARE BEING DELIVERED. When a clinician suspects that the CO 2 absorbent may be desiccated, it should be replaced before administration of sevoflurane. The exothermic reaction that occurs with sevoflurane and CO 2 absorbents is increased WHEN THE CO 2 ABSORBENT BECOMES DESICCATED, SUCH AS AFTER AN EXTENDED PERIOD OF DRY GAS FLOW THROUGH THE CO 2 ABSORBENT CANISTERS. Extremely rare cases of extreme heat, smoke and/or spontaneous fire in the respiratory circuit of the anesthesia machine have been reported Read the complete document